OMID Holdings, Inc. (OMID)
OTC
Healthcare
Drug Manufacturers - Specialty & Generic
$0.02
▲ +0.00%
Market Cap
$1.7M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.84
52-Wk Range
0.015-0.07
CEO
Adam Frank
Country
US
Currency
USD
OMID Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Phillipsburg, NJ, US. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $1.7M. On trailing twelve-month figures it carries a trailing P/E of -10.92, a net margin of -45.1%. Its beta of 1.84 implies it has historically moved more than the broad market.
Valuation & profitability (TTM)
P/E
-10.92
Price / Sales
4.27
Price / Book
21.04
EV / EBITDA
-5.69
Gross margin
-16.8%
Operating margin
-80.2%
Net margin
-45.1%
Return on equity
—
Debt / equity
4.05
Current ratio
28.80
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
6
IPO date
2013-03-21
Headquarters
Phillipsburg, NJ, US
About OMID Holdings, Inc.
OMID Holdings, Inc. operates as a company within the health and wellness sector, specializing in the creation and distribution of products infused with CBD. The firm's main offices are situated in Phillipsburg, New Jersey.
Comparable companies
OMID Holdings, Inc. is most often compared with the following Healthcare names:
More research on OMID
Open full interactive analysis & DCF →